✦ LIBER ✦

Omepmazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H2-receptor antagonists

✍ Scribed by L. LUNDELL; L. BACKMAN; P. EKSTRÖM; L.-H. ENANDER; O. FAUSA; T. LIND; H. LÖNROTH; S. SANDMARK; B. SANDZÉN; P. UNGE; I. H. WESTIN

Book ID: 108602931
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 597 KB
Volume: 4
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.1990.tb00459.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for high-dose H2-receptor bloc

Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease

✍ D. O. CASTELL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

The addition of interferon or high dose

The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma : Phase III Eastern Cooperative Oncology Group clinical trial EST 9486

✍ Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera

A randomized trial of pegylated-interfer

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB